Fiala, O., Finek, J., Poprach, A., Melichar, B., Kopecký, J., Zemanova, M., . . . Buchler, T. (2020). Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients. Cancers (Basel).
Stile di citazione ChicagoFiala, Ondrej, et al. "Outcomes According to MSKCC Risk Score With Focus On the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated With First-Line Sunitinib: A Retrospective Analysis of 2390 Patients." Cancers (Basel) 2020.
Citazione MLAFiala, Ondrej, et al. "Outcomes According to MSKCC Risk Score With Focus On the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated With First-Line Sunitinib: A Retrospective Analysis of 2390 Patients." Cancers (Basel) 2020.